Kim J K, Soubrier F, Michel J B, Bankir L, Corvol P, Schrier R W
Department of Medicine, University of Colorado School of Medicine, Denver 80262.
J Clin Invest. 1990 Jul;86(1):14-6. doi: 10.1172/JCI114676.
The Brattleboro rat, which has an autosomally recessive form of diabetes insipidus, has been reported to have a marked defect in the regulation of arginine vasopressin (AVP) gene expression. However, it is not known whether this is a primary genetic defect or occurs secondary to the urinary water losses which occur in the absence of circulating AVP in the Brattleboro rat. This present study was therefore undertaken to study AVP gene regulation in the Brattleboro rat after chronic AVP treatment by osmotic minipump for 2 wk. In Brattleboro rats without AVP treatment, neither urinary osmolality (Uosm) nor hypothalamic AVP mRNA was significantly changed after 24 h of fluid deprivation (Uosm, 413 +/- 33 to 588 +/- 44, NS; AVP mRNA, 39.33 +/- 2.95 to 46.39 +/- 2.71 pg/micrograms total RNA, NS). In contrast, when Brattleboro rats were treated with AVP for 2 wk, the regulation of AVP gene occurred in response to 24 h of fluid deprivation. In these studies, hypothalamic AVP mRNA was significantly increased compared with the Brattleboro rats still receiving AVP with free access of water (28.9 +/- 3.5 vs. 65.0 +/- 3.3 pg/micrograms total RNA, P less than 0.001). Further studies in Long-Evans rats demonstrate a similar response to a comparable degree of fluid deprivation as Uosm and AVP mRNA were significantly increased after 72 h of fluid deprivation (Uosm, 1,505 +/- 186 to 5,460 +/- 560 mosmol/kg, P less than 0.001; AVP mRNA, 31.7 +/- 3.9 to 77.5 +/- 4.6 pg/micrograms total RNA, P less than 0.001). These results indicate that AVP-replaced homozygous Brattleboro rats can regulate AVP gene expression normally in response to fluid deprivation. This finding indicates that the defect in AVP gene regulation in the Brattleboro rat not receiving AVP replacement is a secondary phenomenon rather than a primary genetic defect.
遗传性尿崩症的布拉德福德大鼠,其常染色体呈隐性形式,据报道在精氨酸加压素(AVP)基因表达调控方面存在明显缺陷。然而,尚不清楚这是原发性基因缺陷,还是在布拉德福德大鼠缺乏循环AVP时因尿液水分流失继发产生的。因此,本研究旨在通过渗透微型泵对布拉德福德大鼠进行2周的慢性AVP治疗后,研究其AVP基因调控情况。在未接受AVP治疗的布拉德福德大鼠中,禁水24小时后尿渗透压(Uosm)和下丘脑AVP mRNA均无显著变化(Uosm,413±33至588±44,无显著性差异;AVP mRNA,39.33±2.95至46.39±2.71 pg/μg总RNA,无显著性差异)。相比之下,如果用AVP对布拉德福德大鼠进行2周治疗,那么在禁水24小时后会出现AVP基因调控。在这些研究中,与仍能自由饮水并接受AVP治疗的布拉德福德大鼠相比,下丘脑AVP mRNA显著增加(28.9±3.5对65.0±3. pg/μg总RNA,P<0.001)。对长-伊文斯大鼠的进一步研究表明,在禁水72小时后,Uosm和AVP mRNA显著增加,对相当程度的禁水有类似反应(Uosm,1505±186至5460±560 mosmol/kg,P<0.001;AVP mRNA,31.7±3.9至77.5±4.6 pg/μg总RNA,P<0.001)。这些结果表明,接受AVP替代治疗的纯合布拉德福德大鼠能够在禁水时正常调节AVP基因表达。这一发现表明,未接受AVP替代治疗的布拉德福德大鼠中AVP基因调控缺陷是一种继发现象,而非原发性基因缺陷。